AR048869A1 - Bencimidazoles triciclicos - Google Patents
Bencimidazoles triciclicosInfo
- Publication number
- AR048869A1 AR048869A1 ARP050101534A ARP050101534A AR048869A1 AR 048869 A1 AR048869 A1 AR 048869A1 AR P050101534 A ARP050101534 A AR P050101534A AR P050101534 A ARP050101534 A AR P050101534A AR 048869 A1 AR048869 A1 AR 048869A1
- Authority
- AR
- Argentina
- Prior art keywords
- 4alkyl
- fluoro
- 4alkoxy
- alkyl
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente trata de bencimidazoles tricíclicos, los compuestos inhiben la secrecion de ácido gástrico. Medicamento y uso. Reivindicacion 1: Un compuesto de la formula (1) en donde R1 es H, halogeno, C1-4 alquilo, C3-7 cicloalquilo, C3-7cicloalquil- C1-4alquilo, C1-4 alcoxi, C1-4alcoxi-C1-4alquilo, C1-4 alcoxicarbonilo, C2-4 alquenilo, C2-4 alquinilo, fluoro-C1-4alquilo, fluoro-C1-4alcoxi-C1-4alquilo o hidroxi-C1-4alquilo, R2 es H, C1-4 alquilo, C3-7 cicloalquilo, C3-7cicloalquil-C1-4alquilo, C1-4alcoxi-C1-4alquilo, C2-4 alquenilo, C2-4 alquinilo, fluoro-C1-4alquilo, o hidroxi-C1-4alquilo; R3 es H, C1-4 alquilo, C3-7 cicloalquilo, C3-7cicloalquil-C1-4alquilo, C1-4alcoxi-C1-4alquilo, fluoro-C1-4alquilo, fluoro-C1-4alcoxi-C1-4alquilo o hidroxi-C1-4 alquilo; R4 es H, C1-4 alquilo, C3-7 cicloalquilo, C3-7cicloalquil-C1-4alquilo, C1-4alcoxi-C1-4alquilo, fluoro-C1-4alquilo, fluoro-C1-4alcoxi-C1-4alquilo, hidroxi-C1-4alquilo, C1-4alcoxi-C1-4alquilcarbonilo, mono- o di-C1-4alquilamino- C1-4alquilcarbonilo o C1-4 alquilcarbonilo o en donde R3 y R4 conjuntamente forman un radical metileno (-CH2-), etileno (-CH2-CH2-), propileno (-CH2-CH2-CH2-) o isopropilideno (-C(CH3)2-); R5 es H, halogeno, C1-4 alquilo o fluoro-C1-4alquilo; R6 es H, halogeno, C1-4 alquilo o fluoro-C1-4alquilo y sus sales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04009793 | 2004-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR048869A1 true AR048869A1 (es) | 2006-06-07 |
Family
ID=34924730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050101534A AR048869A1 (es) | 2004-04-26 | 2005-04-19 | Bencimidazoles triciclicos |
Country Status (8)
Country | Link |
---|---|
US (1) | US20070244173A1 (es) |
EP (1) | EP1742951A1 (es) |
JP (1) | JP2007534680A (es) |
AR (1) | AR048869A1 (es) |
AU (1) | AU2005235754A1 (es) |
CA (1) | CA2563759A1 (es) |
TW (1) | TW200538456A (es) |
WO (1) | WO2005103057A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102470126A (zh) | 2009-07-09 | 2012-05-23 | 拉夸里亚创药株式会社 | 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8604566D0 (sv) * | 1986-10-27 | 1986-10-27 | Haessle Ab | Novel compunds |
SE9602286D0 (sv) * | 1996-06-10 | 1996-06-10 | Astra Ab | New compounds |
AU736767B2 (en) * | 1997-05-28 | 2001-08-02 | Altana Pharma Ag | Fused dihydropyrans |
CZ20023210A3 (cs) * | 2000-03-29 | 2003-01-15 | Altana Pharma Ag | Pyrano(2,3-)imidazo(-1,2-a)pyridinová sloučenina |
HUP0500330A3 (en) * | 2001-08-10 | 2009-12-28 | Altana Pharma Ag | Heterocondensated tricyclic imidazopyridines, their use and pharmaceutical compositions containing them |
AU2004226180A1 (en) * | 2003-04-04 | 2004-10-14 | Altana Pharma Ag | Cyclic benzimidazoles |
-
2005
- 2005-04-19 AR ARP050101534A patent/AR048869A1/es unknown
- 2005-04-22 WO PCT/EP2005/051822 patent/WO2005103057A1/en active Application Filing
- 2005-04-22 AU AU2005235754A patent/AU2005235754A1/en not_active Abandoned
- 2005-04-22 EP EP05740363A patent/EP1742951A1/en not_active Withdrawn
- 2005-04-22 JP JP2007508910A patent/JP2007534680A/ja not_active Withdrawn
- 2005-04-22 CA CA002563759A patent/CA2563759A1/en not_active Abandoned
- 2005-04-25 TW TW094113126A patent/TW200538456A/zh unknown
-
2006
- 2006-10-18 US US11/578,801 patent/US20070244173A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2005103057A8 (en) | 2006-02-16 |
CA2563759A1 (en) | 2005-11-03 |
JP2007534680A (ja) | 2007-11-29 |
TW200538456A (en) | 2005-12-01 |
US20070244173A1 (en) | 2007-10-18 |
WO2005103057A1 (en) | 2005-11-03 |
AU2005235754A1 (en) | 2005-11-03 |
EP1742951A1 (en) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR055071A1 (es) | Derivados de pirrolo (3,2 - b) pirimidina. composiciones farmaceuticas. | |
UY39526A (es) | Inhibidores de kras g12d | |
ES2485867T3 (es) | Compuestos opioides de carboxamido | |
AR075396A1 (es) | Derivados de quinazolinas y composiciones farmaceuticas | |
AR050953A1 (es) | Compuestos de sulfonamida inhibidores de los receptores de cck1/cck2 duales | |
CO5680403A2 (es) | Antagonistas de mchr1r | |
AR069802A1 (es) | Compuestos de carbamoilo como inhibidores de dgat1 190 | |
CO5690593A2 (es) | Nuevos derivados de pirimidin 2-amina | |
ES2604191T3 (es) | Inhibidores de tirosina quinasas | |
CO6220931A2 (es) | Inhibidores de serina proteasas para el tratamiento de infecciones de vhc | |
PE20142081A1 (es) | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodo de uso de los mismos | |
CO6190626A2 (es) | Compuestos y composiciones como inhibidores de proteasa activadora de canal | |
EA201000101A1 (ru) | Производные пиримидина 934 | |
AR067613A1 (es) | Inhibidores de adn-pk, uso y sintesis de los mismos | |
AR071222A1 (es) | Compuestos heterociclicos espirocondensados | |
AR062797A1 (es) | Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas. | |
CO6321266A2 (es) | Inhibidores limk2 compuestos de los cuales estan hechos y metodologia de uso | |
AR093581A1 (es) | Antibioticos macrociclicos de amplio espectro | |
AR054102A1 (es) | Derivados de fenil-piperazina-metanona. procesos de obtencion y composiciones farmaceuticas | |
AR081828A1 (es) | Compuestos de biguanida y su uso para el tratamiento del cancer | |
AR066604A1 (es) | Derivados de arilamida pirimidona, medicamentos que los contienen y usos terapeuticos para prevenir y/o tratar enfermedades neurodegenerativas fundamentalmente. | |
CO5601021A2 (es) | Derivados de quinazolinona, composiciones farmaceuticas que los contienen y su proceso de preparacion y su uso como antagonistas cb | |
UY30787A1 (es) | "inhibidores benzoimidazolicos de trpv1" | |
RS54120B1 (en) | Pyridinyl-I pyrazinyl-methyloxyaryl derivatives USED AS INHIBITORS OF TYROSINE KINASE TREATMENT (SYK) | |
AR054132A1 (es) | Derivados de azolopiridin-2-ona como inhibidores de lipasas y fosfolipasas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |